Researchers are working to expand CAR-T therapy beyond blood cancers into solid tumors, autoimmune diseases, and more. By overcoming current limitations, CAR-T has the potential to revolutionize medicine, making immune-based treatments more effective, durable, and widely available worldwide. https://www.xelleratherapeutics.com/services/custom-manufacturing-services/